Adenosine diphosphate receptor inhibitor
Adenosine diphosphate (ADP) receptor inhibitor is a class of antiplatelet agents. These drugs inhibit some or all types of adenosine diphosphate receptors (P2Y receptors). P2Y receptors are a family of purinergic G protein-coupled receptors, stimulated by nucleotides such as ATP, ADP, UTP, UDP and UDP-glucose.
- Hashemzadeh, M; Goldsberry, S; Furukawa, M; Khoynezhad, A; Movahed, MR (2009). "ADP receptor-blocker thienopyridines: Chemical structures, mode of action and clinical use. A review". The Journal of invasive cardiology 21 (8): 406–12. PMID 19652255.
- Bauer, Shawn M (2003). "ADP receptor antagonists as antiplatelet therapeutics". Expert Opinion on Emerging Drugs 8 (1): 93–101. doi:10.1517/1472818.104.22.168. PMID 14610915.
- Michelson, AD (2009). "New P2Y12 antagonists". Current Opinion in Hematology 16 (5): 371–7. doi:10.1097/MOH.0b013e32832ea2f2. PMID 19550317.
|This drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by expanding it.|